Solventum Corporation SOLV
Set alert
At close · Oct 30
After hours · Oct 30, 4:02 PM ET
- YTD
- +2.64%
- 1 year
- +17.39%
- Open
- 84.15
- Prev close
- 83.56
- Mkt cap
- 13.84B
- Vol
- 1.07M
- Avg vol
- 1.04M
- EPS
- 8.17
- P/E
- 9.95
- Div yield
- 0.00%
More statistics
- Low
- 80.76
- High
- 84.48
- Forward P/E
- 11.19
- Beta
- 0.70
- Short ratio
- 5.04
- Inst. own
- 75.94%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 88.24
- 200-d avg
- 78.36
- 1y target
- 94.69
5Y chart
Events in this range
- Aug 7, 2025Earnings: 1.69; estimate 1.45; surprise 16.55%
- Nov 6, 2025Earnings: 1.5; estimate 1.43; surprise 4.9%
- Feb 26, 2026Earnings: 1.57; estimate 1.5; surprise 4.67%
- May 5, 2026Earnings: 1.48; estimate 1.35; surprise 9.63%
- Aug 5, 2026Earnings: 2.55; estimate 1.9; surprise 34.21%
- Aug 6, 2026Rating: Stifel · Buy → Buy
- Aug 6, 2026Rating: Keybanc · Overweight → Overweight
- Aug 6, 2026Rating: Wedbush · Outperform → Outperform
- Aug 6, 2026Rating: Piper Sandler · Overweight → Overweight
- Aug 6, 2026Rating: UBS · Buy → Buy
- Sep 14, 2026Rating: BTIG · Buy → Buy
- Nov 5, 2026Earnings: —; estimate 1.34; surprise —%
Signals (53)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 11, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 26, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 16, 2024 | 1 year ago |
| SMA: Bearish | Dec 2, 2024 | 1 year ago |
| SMA: Bullish | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Jul 22, 2024 | 2 years ago |
Key statistics
- Market cap
- 13.84B
- Enterprise value
- 19.12B
- Trailing P/E
- 9.95
- Forward P/E
- 11.19
- PEG ratio
- 1.22
- Price / sales
- 1.67
- Price / book
- 2.88
- EPS (TTM)
- 8.17
- Beta
- 0.70
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 17.26%
- Revenue (TTM)
- 8.31B
- Revenue growth
- 2.20%
- Free cash flow
- 489.00M
- Total cash
- 403.00M
- Total debt
- 5.30B
- Return on equity
- 33.96%
- Shares outstanding
- 170.22M
- Short % of float
- 3.43%
- 50-day average
- 88.24
- 200-day average
- 78.36
Analyst view
Consensus: buy
- Target (low)
- 71.00
- Target (mean)
- 94.69
- Target (high)
- 113.00
- Strong buy1
- Buy7
- Hold5
- Sell1
- Strong sell1
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 1.34.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 1.34 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 1.90 | 2.55 | +0.65 | +34.21% |
| May 5, 2026 | Mar 31, 2026 | 1.35 | 1.48 | +0.13 | +9.63% |
| Feb 26, 2026 | Dec 31, 2025 | 1.50 | 1.57 | +0.07 | +4.67% |
| Nov 6, 2025 | Sep 30, 2025 | 1.43 | 1.50 | +0.07 | +4.90% |
| Aug 7, 2025 | Jun 30, 2025 | 1.45 | 1.69 | +0.24 | +16.55% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 14, 2026 | BTIG | reit | Buy | Buy |
| Aug 6, 2026 | UBS | main | Buy | Buy |
| Aug 6, 2026 | Piper Sandler | main | Overweight | Overweight |
| Aug 6, 2026 | Wedbush | main | Outperform | Outperform |
| Aug 6, 2026 | Keybanc | main | Overweight | Overweight |
| Aug 6, 2026 | Stifel | main | Buy | Buy |
About Solventum Corporation
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- solventum.com
News
- Solventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
- Here's Why Solventum (SOLV) is a Strong Value Stock
- Solventum Receives FDA Clearance For Combined Use Of Restrata Synthetic Electrospun Fiber Matrix, Solventum V.A.C. Therapy
- UBS Maintains Buy on Solventum, Raises Price Target to $101
- Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105
- Wedbush Maintains Outperform on Solventum, Raises Price Target to $101
- Keybanc Maintains Overweight on Solventum, Raises Price Target to $102
- Stifel Maintains Buy on Solventum, Raises Price Target to $100
- BTIG Maintains Buy on Solventum, Raises Price Target to $95
- Solventum Plans To Separate Its Health Information Systems Operations As Part Of Its Portfolio Optimization Strategy
Your note
Sign in to keep a note on SOLV — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| 3M CO | Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 14, 2025 | 25,569,200 |
| COX CARRIE SMITH | Director | Conversion of Exercise of derivative security | Apr 29, 2026 | 16,400 |
| GOMEZ TAMMY L | Officer | Conversion of Exercise of derivative security | May 12, 2026 | 13,362 |
| HANSON BRYAN CRAIG | Chief Executive Officer | Conversion of Exercise of derivative security | Aug 31, 2026 | 185,515 |
| HARRINGTON PAUL S | Officer | Conversion of Exercise of derivative security | May 12, 2026 | 20,452 |
| KIRBERGER MARCELA A. | Officer | Conversion of Exercise of derivative security | May 12, 2026 | 13,540 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Independent Franchise Partners, LLP | 9.50% | 16,170,038 | 1.31B | Jun 29, 2026 |
| Blackrock Inc. | 5.73% | 9,761,863 | 793.74M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 5.65% | 9,624,829 | 782.59M | Jun 29, 2026 |
| Trian Fund Management, LP | 4.84% | 8,236,753 | 669.73M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 3.72% | 6,328,641 | 514.58M | Jun 29, 2026 |
| Davis Selected Advisers | 3.71% | 6,307,729 | 512.88M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.75% | 4,674,934 | 380.12M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.24% | 3,816,022 | 310.28M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.98% | 3,375,087 | 274.43M | Jun 29, 2026 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.40% | 2,385,590 | 193.97M | Aug 30, 2026 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 1.28% | 2,172,808 | 176.67M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.26% | 2,138,463 | 173.88M | Jun 29, 2026 |